Embryonic stem cells morph into heart cells
Could be useful for drug testing
Scientists have succeeded in turning human embryonic stem cells into three types of heart muscle cells, although they warn that therapeutic applications are still far off. Instead, the cells will be used for drug tests. "We have now a supply of human heart cells for biotech and drug companies to start testing the beneficial effects of drugs or the toxic effects of drugs," says Toronto researcher Gordon Keller, the lead author on an article in Nature. And Ralph Snodgrass, of VistaGen, a company involved in the research described it as "another step towards generating and validating functional human heart cells at a scale and purity that is necessary for pharmaceutical discovery applications and for predictive toxicity screening of new drug candidates." ~ Washington Post, Apr 23
Michael Cook edits BioEdge, a bioethics newsletter, and MercatorNet, an on-line magazine whose focus is human dignity. He writes from Sydney, Australia.
Latest posts by Michael Cook (see all)
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
A painful debate: shrinking the carbon footprint of anaesthetics
If there is any profession which seems remote from the Sturm und Drang of climate change, it must be anaesthetists....
Some patients recall death experiences after heart attacks
In an article in the journal Resuscitation, some survivors of cardiac arrest have described lucid death experiences that occurred while...
Queensland widower dies after taking assisted suicide drugs ordered by his wife
“Move along, please. Nothing to see here.” This was more or less the reaction of supporters of “voluntary assisted dying”...
Australian first: nurse donates organs after euthanasia
A Victorian woman has become the first Australian to combine death by euthanasia with organ donation. Ballarat nurse Marlene Bevern,...
Canadian study hints at crushing institutional conscience objections to ‘assisted dying’
Supporters of “voluntary assisted dying” fought hard to achieve legalisation in various jurisdictions around the world. After legalisation, however, battles...
Hope, hype and xenotransplantation
On January 7, 2022 David Bennett, a 57-year-old with terminal heart disease, made history as the first person to receive...